Jianhua Cai

Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment

Xiaoyan Jiang, Xiaosong Zhu, Hongya Xu et al. · Acta Pharmacologica Sinica · 2017 · 68 citations · Full text

Tumor Biology, Gastric Cancer Treatment, Oncology +9

CHD1L promotes tumor progression and predicts survival in colorectal carcinoma

Xiaopin Ji, Jianfang Li, Li Zhu et al. · Journal of Surgical Research · 2013 · 38 citations

Medicine, Tumor Progression, Pathology +8

Expression of Cortactin Correlates with a Poor Prognosis in Patients with Stages II–III Colorectal Adenocarcinoma

Jianhua Cai, Ren Zhao, Jianwei Zhu et al. · Journal of Gastrointestinal Surgery · 2010 · 30 citations

Prognostic Biomarkers, Medicine, Cortactin Correlates +7

Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial

Hui Zhao, Xiaosong Li, Dianjun Chen et al. · Medical Oncology · 2015 · 30 citations

Intraperitoneal Administration, Medicine, Cancer Management +8

Diallyl Trisulfide Inhibits Growth of NCI-H460 <i>in Vitro </i>and <i>in Vivo</i>, and Ameliorates Cisplatin-Induced Oxidative Injury in the Treatment of Lung Carcinoma in Xenograft Mice

Xiaoyan Jiang, Xiaosong Zhu, Na Liu et al. · International Journal of Biological Sciences · 2017 · 30 citations · Full text